Drugs / DA-6886
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01633723 | Aug 2012 → Apr 2014 | irritable bowel syndrome | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-6886 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01633723 ↗ |
| Modality | Small molecule | — CHEMBL3950712 ↗ |
| Route | Oral | “After oral administration” NCT01633723 ↗ |